Not finding it? Sign in to also search OpenAlex live.
-
The landscape of tertiary lymphoid structures in endometrial cancer revealed through harmonized multi-level transcriptomics2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access
Marta Requesens, Koen Brummel, Arkajyoti Bhattacharya, Feija Somefun, Nienke van Rooij, Annechien Plat, +10 more
0citations -
Reply to: “Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743” and “Beyond Statistical Significance: Methodologic Fragility and Censoring Bias in the 5-Year Update of CheckMate 743”
Arnaud Scherpereel, Aaron Scott Mansfield, Francesco Grossi, Sanjay Popat, Paul Baas, Anna K. Nowak, +14 more
0citations -
Mass cytometry-based deep immune cell profiling of metastatic clear cell renal cell carcinoma patients refractory to combined immune checkpoint and tyrosine kinase inhibitor therapy.2025 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Luigi Formisano, Stefania Belli, Angela Vallefuoco, Giovanna Pecoraro, Fortuna Migliaccio, Chiara Barraco, +7 more
0citations -
OPTIM: a randomized phase II trial of nivolumab followed by nivolumab-ipilimumab or docetaxel at progression in recurrent/metastatic squamous cell carcinoma of the head and neck (OPTIM; AIO-KHT-0117)
Viktor Grünwald, Jurgen Alt, Mareike Tometten, Mathias Hänel, Philipp Ivanyi, Gunter Schuch, +7 more
0citations -
721 AT1412, a patient-derived CD9 antibody in preclinical development promoting tumor immune infiltration and inducing tumor rejection2020 Regular and Young Investigator Award Abstracts conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Remko Schotte, Julien Villaudy, Martijn Kedde, Wouter Pos, Daniel Go, Christien Fatmawati, +10 more
0citations -
Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review
Manuel Stöth, Till Jasper Meyer, Thomas Eckhard Gehrke, Rudolf Hagen, Matthias Scheich, Stephan Hackenberg, +1 more
6citations -
Abstract CT194: Low-dose Interferon-alpha pre-conditioning and adoptive cell therapy in metastatic melanoma patients refractory to standard (immune) therapies - a phase 1/2 study
Monique K. van der Kooij, Els M.E. Verdegaal, Marten Visser, Carolien E. van der Minne, Linda de Bruin, Pauline Meij, +8 more
0citations -
CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors2024 Cellular and Molecular Immunology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
Xin Lei, Daniël de Groot, Marij J.P. Welters, Tom de Wit, Ellen Schrama, Hans van Eenennaam, +10 more
65citations